Cowen Prime Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $6.81K | Sell |
59
-400
| -87% | -$45.4K | ﹤0.01% | 180 |
|
|
2023
Q1 | $53K | Buy |
459
+59
| +15% | +$6.37K | 0.02% | 131 |
|
|
2022
Q4 | $44K | Hold |
400
| – | – | 0.02% | 132 |
|
|
2022
Q3 | $34K | Hold |
400
| – | – | 0.02% | 123 |
|
|
2022
Q2 | $36K | Hold |
400
| – | – | 0.02% | 127 |
|
|
2022
Q1 | $33K | Hold |
400
| – | – | 0.01% | 136 |
|
|
2021
Q4 | $31K | Hold |
400
| – | – | 0.01% | 134 |
|
|
2021
Q3 | $30K | Hold |
400
| – | – | 0.01% | 132 |
|
|
2021
Q2 | $31K | Sell |
400
-19
| -5% | -$1.41K | 0.01% | 127 |
|
|
2021
Q1 | $31K | Hold |
419
| – | – | 0.01% | 126 |
|
|
2020
Q4 | $33K | Hold |
419
| – | – | 0.01% | 125 |
|
|
2020
Q3 | $33K | Hold |
419
| – | – | 0.02% | 129 |
|
|
2020
Q2 | $36K | Hold |
419
| – | – | 0.02% | 126 |
|
|
2020
Q1 | $31K | Hold |
419
| – | – | 0.02% | 128 |
|
|
2019
Q4 | $36K | Hold |
419
| – | – | 0.02% | 122 |
|
|
2019
Q3 | $34K | Hold |
419
| – | – | 0.02% | 118 |
|
|
2019
Q2 | $34K | Hold |
419
| – | – | 0.02% | 126 |
|
|
2019
Q1 | $33K | Hold |
419
| – | – | 0.02% | 130 |
|
|
2018
Q4 | $31K | Hold |
419
| – | – | 0.02% | 133 |
|
|
2018
Q3 | $28K | Hold |
419
| – | – | 0.01% | 160 |
|
|
2018
Q2 | $24K | Hold |
419
| – | – | 0.01% | 165 |
|
|
2018
Q1 | $22K | Hold |
419
| – | – | 0.01% | 163 |
|
|
2017
Q4 | $23K | Sell |
419
-1,048
| -71% | -$58.1K | 0.01% | 162 |
|
|
2017
Q3 | $90K | Hold |
1,467
| – | – | 0.04% | 108 |
|
|
2017
Q2 | $90K | Hold |
1,467
| – | – | 0.04% | 111 |
|
|
2017
Q1 | $89K | Buy |
1,467
+1,048
| +250% | +$63.6K | 0.05% | 110 |
|
|
2016
Q4 | $24K | Hold |
419
| – | – | 0.01% | 154 |
|
|
2016
Q3 | $25K | Hold |
419
| – | – | 0.01% | 190 |
|
|
2016
Q2 | $23K | Hold |
419
| – | – | 0.01% | 170 |
|
|
2016
Q1 | $21K | Hold |
419
| – | – | 0.01% | 170 |
|
|
2015
Q4 | $21K | Hold |
419
| – | – | 0.01% | 174 |
|
|
2015
Q3 | $20K | Hold |
419
| – | – | 0.01% | 183 |
|
|
2015
Q2 | $23K | Sell |
419
-198
| -32% | -$11.1K | 0.01% | 184 |
|
|
2015
Q1 | $34K | Buy |
617
+1
| +0.2% | +$57 | 0.01% | 200 |
|
|
2014
Q4 | $33K | Buy |
616
+105
| +21% | +$5.85K | 0.01% | 215 |
|
|
2014
Q3 | $29K | Sell |
511
-511
| -50% | -$28.7K | 0.01% | 212 |
|
|
2014
Q2 | $56K | Buy |
1,022
+5
| +0.5% | +$273 | 0.02% | 168 |
|
|
2014
Q1 | $55K | Sell |
1,017
-26
| -2% | -$1.35K | 0.02% | 165 |
|
|
2013
Q4 | $50K | Sell |
1,043
-88
| -8% | -$4.02K | 0.02% | 178 |
|
|
2013
Q3 | $52K | Buy |
1,131
+188
| +20% | +$8.58K | 0.02% | 183 |
|
|
2013
Q2 | $42K | Buy |
+943
| New | +$42.1K | 0.02% | 188 |
|
Other funds holding MRK
Cowen Prime Advisors's MRK Position: Q2 2023 in Review
Cowen Prime Advisors reduced its Merck (MRK) stake by 87% in Q2 2023, selling an estimated $45.4K and leaving 59 shares worth $6.81K. The position accounts for ﹤0.01% of the portfolio, ranked #180.
Cowen Prime Advisors first reported a position in MRK in Q2 2013 and has held it in 41 quarters since. The position peaked at $90K in Q3 2017. 3,256 funds tracked by Wall St. Rank hold MRK as of Q2 2023.
- Cowen Prime Advisors held 59 shares of Merck worth $6.81K as of Q2 2023.
- Cowen Prime Advisors sold 400 Merck shares in Q2 2023, an estimated $45.4K.
- Merck made up ﹤0.01% of Cowen Prime Advisors's portfolio in Q2 2023, its #180 holding.
- Cowen Prime Advisors first reported a position in Merck in Q2 2013 and has held it in 41 quarters since.
- Cowen Prime Advisors's Merck position peaked at $90K in Q3 2017.
- 3,256 funds tracked by Wall St. Rank held Merck as of Q2 2023.
Based on Cowen Prime Advisors's 13F filing for Q2 2023, filed 31 Jul 2023.